Search Results

There are 8823 results for: content related to: Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

  1. You have free access to this content
    Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group

    Pediatric Blood & Cancer

    Volume 63, Issue 6, June 2016, Pages: 973–982, Uma H. Athale, Paul J. Gibson, Nicole M. Bradley, David M. Malkin and Johann Hitzler

    Version of Record online : 23 FEB 2016, DOI: 10.1002/pbc.25939

  2. You have free access to this content
    Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time-points reveals high levels of concordance between molecular and immunophenotypic approaches

    British Journal of Haematology

    Volume 144, Issue 1, January 2009, Pages: 107–115, Jacqueline Ryan, Fiona Quinn, Armelle Meunier, Ludmila Boublikova, Mireille Crampe, Prerna Tewari, Aengus O’Marcaigh, Ray Stallings, Michael Neat, Ann O’Meara, Fin Breatnach, Shaun McCann, Paul Browne, Owen Smith and Mark Lawler

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07429.x

  3. You have free access to this content
    Detection of minimal residual disease in pediatric acute lymphoblastic leukemia

    Cytometry Part B: Clinical Cytometry

    Volume 84, Issue 6, November/December 2013, Pages: 359–369, Giuseppe Gaipa, Giuseppe Basso, Andrea Biondi and Dario Campana

    Version of Record online : 26 JUN 2013, DOI: 10.1002/cyto.b.21101

  4. The detection and significance of minimal residual disease in acute and chronic leukemia

    Tissue Antigens

    Volume 68, Issue 5, November 2006, Pages: 371–385, N.-G. Chung, V. Buxhofer-Ausch and J. P. Radich

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1399-0039.2006.00714.x

  5. You have free access to this content
    Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 155, Issue 1, October 2011, Pages: 45–52, Giovanni Cazzaniga, Maria Grazia Valsecchi, Giuseppe Gaipa, Valentino Conter and Andrea Biondi

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08795.x

  6. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 168, Issue 3, February 2015, Pages: 395–404, Rosemary Sutton, Peter J. Shaw, Nicola C. Venn, Tamara Law, Anuruddhika Dissanayake, Tatjana Kilo, Michelle Haber, Murray D. Norris, Chris Fraser, Frank Alvaro, Tamas Revesz, Toby N. Trahair, Luciano Dalla-Pozza, Glenn M. Marshall and Tracey A. O'Brien

    Version of Record online : 13 OCT 2014, DOI: 10.1111/bjh.13142

  7. Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 5, September/October 2015, Pages: 294–304, Joseph A. DiGiuseppe, Michelle D. Tadmor and Dana Pe'er

    Version of Record online : 2 JUN 2015, DOI: 10.1002/cyto.b.21252

  8. You have free access to this content
    Status of minimal residual disease testing in childhood haematological malignancies

    British Journal of Haematology

    Volume 143, Issue 4, November 2008, Pages: 481–489, Dario Campana

    Version of Record online : 15 AUG 2008, DOI: 10.1111/j.1365-2141.2008.07350.x

  9. You have free access to this content
    Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

    British Journal of Haematology

    Volume 128, Issue 6, March 2005, Pages: 774–782, Gunter Kerst, 1 Hermann Kreyenberg, 2 Carmen Roth, 1 Catrin Well, 1 Klaus Dietz, 3 Elaine Coustan-Smith, 4 Dario Campana, 4 Ewa Koscielniak, 5 Charlotte Niemeyer, 6 Paul G. Schlegel, 7 Ingo Müller, 1 Dietrich Niethammer and 1 Peter Bader 2

    Version of Record online : 8 MAR 2005, DOI: 10.1111/j.1365-2141.2005.05401.x

  10. You have free access to this content
    Determination of minimal residual disease in leukaemia patients

    British Journal of Haematology

    Volume 121, Issue 6, June 2003, Pages: 823–838, Dario Campana

    Version of Record online : 3 JUN 2003, DOI: 10.1046/j.1365-2141.2003.04393.x

  11. You have free access to this content
    Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 1, January 2015, Pages: 21–29, Chantal Fossat, Mikael Roussel, Isabelle Arnoux, Vahid Asnafi, Chantal Brouzes, Francine Garnache-Ottou, Marie-Christine Jacob, Emilienne Kuhlein, Elizabeth Macintyre-Davi, Adriana Plesa, Nelly Robillard, Jean Tkaczuk, Norbert Ifrah, Herve Dombret, Marie C. Béné, Andre Baruchel, Richard Garand and for the French Multicenter Study Groups for Pediatric and Adult ALL

    Version of Record online : 1 NOV 2014, DOI: 10.1002/cyto.b.21195

  12. You have free access to this content
    Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

    British Journal of Haematology

    Volume 148, Issue 1, January 2010, Pages: 80–89, Bella Patel, Lena Rai, Georgina Buck, Sue M. Richards, Yeasmin Mortuza, Wayne Mitchell, Gareth Gerrard, Anthony V. Moorman, Veronique Duke, A. Victor Hoffbrand, Adele K. Fielding, Anthony H. Goldstone and Letizia Foroni

    Version of Record online : 26 OCT 2009, DOI: 10.1111/j.1365-2141.2009.07941.x

  13. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  14. You have free access to this content
    Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia

    Cytometry Part B: Clinical Cytometry

    Volume 78B, Issue 6, November 2010, Pages: 365–371, Drorit Luria, Eti Rosenthal, David Steinberg, Yona Kodman, Marina Safanaiev, Ninette Amariglio, Smadar Avigad, Batia Stark, Shai Izraeli and for the Israel National Study Group of Childhood ALL

    Version of Record online : 25 OCT 2010, DOI: 10.1002/cyto.b.20532

  15. You have free access to this content
    Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: Potential usefulness in minimal residual disease detection

    Cytometry Part B: Clinical Cytometry

    Volume 76B, Issue 2, March 2009, Pages: 150–155, Joseph A. DiGiuseppe, Sheila G. Fuller and Michael J. Borowitz

    Version of Record online : 1 OCT 2008, DOI: 10.1002/cyto.b.20440

  16. You have free access to this content
    Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

    British Journal of Haematology

    Volume 134, Issue 3, August 2006, Pages: 273–282, Nick Goulden, Paul Virgo and David Grimwade

    Version of Record online : 29 JUN 2006, DOI: 10.1111/j.1365-2141.2006.06182.x

  17. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014

    Pediatric Blood & Cancer

    Volume 61, Issue S2, December 2014, Pages: S105–S433,

    Version of Record online : 16 OCT 2014, DOI: 10.1002/pbc.25314

  18. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: A report from the Japanese Childhood Cancer and Leukemia Study Group

    Pediatric Blood & Cancer

    Volume 55, Issue 7, 15 December 2010, Pages: 1287–1295, Kazutaka Yamaji, Tomomi Okamoto, Shohei Yokota, Arata Watanabe, Yasuo Horikoshi, Keiko Asami, Atsushi Kikuta, Nobuyuki Hyakuna, Yutaka Saikawa, Junichi Ueyama, Tsutomu Watanabe, Masahiko Okada, Takashi Taga, Hirokazu Kanegane, Kazuhiro Kogawa, Motoaki Chin, Asayuki Iwai, Takeshi Matsushita, Yasuto Shimomura, Toshinori Hori, Masahito Tsurusawa and for The Japanese Childhood Cancer, Leukemia Study Group (JCCLSG)

    Version of Record online : 25 OCT 2010, DOI: 10.1002/pbc.22620

  19. You have free access to this content
    Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation

    British Journal of Haematology

    Volume 162, Issue 2, July 2013, Pages: 147–161, Dario Campana and Wing Leung

    Version of Record online : 9 MAY 2013, DOI: 10.1111/bjh.12358

  20. You have free access to this content
    Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country

    Cytometry Part B: Clinical Cytometry

    Volume 82B, Issue 4, July 2012, Pages: 252–258, Nikhil Patkar, Ansu Abu Alex, Bargavi B., Rayaz Ahmed, Aby Abraham, Biju George, Auro Vishwabandya, Alok Srivastava and Vikram Mathews

    Version of Record online : 29 MAR 2012, DOI: 10.1002/cyto.b.21017